Full Text View
Tabular View
No Study Results Posted
Related Studies
Biobank For MS And Other Demyelinating Diseases
This study is currently recruiting participants.
Verified March 2010 by Accelerated Cure Project for Multiple Sclerosis

First Received on March 8, 2007.   Last Updated on March 10, 2010   History of Changes
Sponsor: Accelerated Cure Project for Multiple Sclerosis
Information provided by: Accelerated Cure Project for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00445367
  Purpose

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.


Condition
Multiple Sclerosis
Transverse Myelitis
Neuromyelitis Optica
Acute Disseminated Encephalomyelitis
Optic Neuritis

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases

Resource links provided by NLM:


Further study details as provided by Accelerated Cure Project for Multiple Sclerosis:

Study Start Date: May 2006
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls.

Criteria

Inclusion Criteria:

  • age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
  • willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture
  • experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON

Exclusion Criteria:

  • history of blood borne pathogens
  • allogeneic bone marrow transplant
  • clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
  • weight less than 37 pounds
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00445367

Contacts
Contact: Sara Loud 781-487-0032 acp-study-director0807@acceleratedcure.org
Contact: Email: acp-study-director0807 /at/ acceleratedcure.org

Locations
United States, Arizona
Barrow Neurological Institute Recruiting
Phoenix, Arizona, United States, 85013
Contact: Breanna Bullock     602-406-6211        
Contact: Email: acp-study-barrow0807 /at/ acceleratedcure.org            
Principal Investigator: Roberto Bomprezzi, M.D.            
United States, California
Stanford University Recruiting
Stanford, California, United States, 94305
Contact: Daniel Lebus     650-723-3657        
Principal Investigator: Lawrence Steinman, M.D.            
United States, Colorado
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver Recruiting
Aurora, Colorado, United States, 80045
Contact: Sydni Edwards     303-724-2197        
Contact: Email: acp-study-director0807/at/acceleratedcure.org            
Principal Investigator: Timothy Vollmer, M.D.            
United States, Georgia
Shepherd Center Recruiting
Atlanta, Georgia, United States, 30309
Contact: Elizabeth Iski     404-350-3116        
Contact: Email: acp-study-shepherd0807 /at/ acceleratedcure.org            
Principal Investigator: Benjamin Thrower, M.D.            
United States, Maryland
Johns Hopkins Recruiting
Baltimore, Maryland, United States, 21287
Contact: Jana Goins     410-502-6160        
Contact: Email: acp-study-hopkins0807 /at/ acceleratedcure.org            
Principal Investigator: Arun Venkatesan, M.D.            
United States, Massachusetts
Beth Israel Deaconess Recruiting
Boston, Massachusetts, United States, 02215
Contact: Sarah Konkel     617-667-3726        
Contact: Email: acp-study-director0807/at/acceleratedcure.org            
Principal Investigator: R. Phillip Kinkel, M.D.            
University of Massachusetts Medical School Recruiting
Worcester, Massachusetts, United States, 01605
Contact: Janice Weaver     508-793-6562        
Contact: Email: acp-study-umass0807 /at/ acceleratedcure.org            
Principal Investigator: Peter Riskind, M.D.            
United States, New York
Multiple Sclerosis Research Center of New York Recruiting
New York, New York, United States, 10019
Contact: Lauren Puccio     212-265-8070        
Contact: Email: acp-study-msrcny0807 /at/ acceleratedcure.org            
Principal Investigator: Saud Sadiq, M.D.            
United States, Ohio
The Ohio State University Recruiting
Columbus, Ohio, United States, 43210
Contact: Jamie McGowan     614-247-6856        
Contact: Email: acp-study-director0807/at/acceleratedcure.org            
Principal Investigator: Michael Racke, M.D.            
United States, Texas
University of Texas Southwestern Medical Center at Dallas Recruiting
Dallas, Texas, United States, 76051
Contact: Stephanie Taylor     214-648-2907        
Contact: Email: acp-study-utsw0807 /at/ acceleratedcure.org            
Principal Investigator: Elliot Frohman, M.D.            
Sponsors and Collaborators
Accelerated Cure Project for Multiple Sclerosis
Investigators
Principal Investigator: Benjamin Greenberg, M.D., M.H.S. Johns Hopkins University
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00445367     History of Changes
Other Study ID Numbers: ACP-001
Study First Received: March 8, 2007
Last Updated: March 10, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Accelerated Cure Project for Multiple Sclerosis:
Multiple Sclerosis
Clinically Isolated Syndrome
Transverse Myelitis
Neuromyelitis Optica
Acute Disseminated Encephalomyelitis
Optic Neuritis
Repository
Biobank

Additional relevant MeSH terms:
Demyelinating Diseases
Encephalomyelitis, Acute Disseminated
Encephalomyelitis
Multiple Sclerosis
Myelitis
Myelitis, Transverse
Neuritis
Neuromyelitis Optica
Optic Neuritis
Sclerosis
Nervous System Diseases
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Leukoencephalopathies
Brain Diseases
Central Nervous System Diseases
Autoimmune Diseases
Immune System Diseases
Encephalitis
Central Nervous System Infections
Central Nervous System Viral Diseases
Virus Diseases
Spinal Cord Diseases
Paraneoplastic Syndromes, Nervous System
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
Paraneoplastic Syndromes
Neurodegenerative Diseases
Peripheral Nervous System Diseases

ClinicalTrials.gov processed this record on February 09, 2012